PAN-Biotech Penicillin-Streptomycin-Amphotericin B Mix (10,000 U/ml Penicillin, 10 mg/ml Streptomycin, 25 µg/ml Amphotericin B) in 0.85% Saline Solution, 50 ml bottle, cell culture media supplement, cat. no. P06-07350, distributed by Ilex Life Sciences.
PAN-Biotech Penicillin-Streptomycin-Amphotericin B Mix (10,000 U/ml Penicillin, 10 mg/ml Streptomycin, 25 µg/ml Amphotericin B) in 0.85% Saline Solution, 100 ml bottle, cell culture media supplement, cat. no. P06-07300, distributed by Ilex Life Sciences.
PAN-Biotech Penicillin-Streptomycin-Amphotericin B Mix (10,000 U/ml Penicillin, 10 mg/ml Streptomycin, 25 µg/ml Amphotericin B) in 0.85% Saline Solution, 25 x 5 ml, cell culture media supplement, cat. no. P06-07325, distributed by Ilex Life Sciences.
  • Load image into Gallery viewer, PAN-Biotech Penicillin-Streptomycin-Amphotericin B Mix (10,000 U/ml Penicillin, 10 mg/ml Streptomycin, 25 µg/ml Amphotericin B) in 0.85% Saline Solution, 50 ml bottle, cell culture media supplement, cat. no. P06-07350, distributed by Ilex Life Sciences.
  • Load image into Gallery viewer, PAN-Biotech Penicillin-Streptomycin-Amphotericin B Mix (10,000 U/ml Penicillin, 10 mg/ml Streptomycin, 25 µg/ml Amphotericin B) in 0.85% Saline Solution, 100 ml bottle, cell culture media supplement, cat. no. P06-07300, distributed by Ilex Life Sciences.
  • Load image into Gallery viewer, PAN-Biotech Penicillin-Streptomycin-Amphotericin B Mix (10,000 U/ml Penicillin, 10 mg/ml Streptomycin, 25 µg/ml Amphotericin B) in 0.85% Saline Solution, 25 x 5 ml, cell culture media supplement, cat. no. P06-07325, distributed by Ilex Life Sciences.

PAN-Biotech Penicillin-Streptomycin-Amphotericin B Mix (10,000 U/ml Penicillin, 10 mg/ml Streptomycin, 25 µg/ml Amphotericin B) in 0.85% Saline Solution

P06-07350
$49.00
$49.00
$58.00
Unavailable
Shipping calculated at checkout.

Introduction

PAN-Biotech Penicillin-Streptomycin-Amphotericin B Mix in 0.85% Saline Solution contains 10,000 U/ml Penicillin, 10 mg/ml Streptomycin, and 25 µg/ml Amphotericin B.

The antibiotics penicillin and streptomycin (together known as Pen-Strep) are used to prevent bacterial contamination of cell cultures to due their effective combined action against gram-positive and gram-negative bacteria. Penicillin was originally purified from the fungus Penicillium and acts by interfering directly with the turnover of the bacterial cell wall and indirectly by triggering the release of enzymes that further alter the cell wall. Streptomycin was originally purified from Streptomyces griseus. It acts by binding to the 30S subunit of the bacterial ribosome, leading to inhibition of protein synthesis and death in susceptible bacteria.

Amphotericin B is an antifungal agent produced by Streptomyces sp.. Amphotericin B increases fungal plasma membrane permeability by binding to sterols, thereby protecting cell cultures from contamination by yeast and multicellular fungi.

Application

Penicillin-Streptomycin-Amphotericin B Mix is used to supplement cell culture media to control both bacterial and fungal contamination.

Composition

Components Concentration 
Amphotericin B: 25.00 mg/L
Streptomycin sulfate: 10,000.00 mg/L
Sodium chloride: 8,500.00 mg/L
Penicillin G potassium salt: 10,000,000.00 Units/L

Specifications

Liquid / Powder: Liquid
Product Category: Antibiotics and Antifungal Drugs
Product Type: Penicillin-Streptomycin-Amphotericin B
Size: 50 ml, 100 ml, 6 x 100 ml, 25 x 5 ml
Sterile: Yes
Storage Temperature: -20°C
Manufacturer: PAN-Biotech GmbH
Country of Origin: Germany

Usage

This product is intended for Laboratory Research Use Only. Not for use in diagnostic or therapeutic procedures. This product may not be used as a pharmaceutical or veterinary drug, agricultural product, or food additive.

Documents

Product References

  • Sondej, Daria et al. “Is laccase from medicinal mushroom Cerrena unicolor cytotoxic to colon cancer cell line CT-26?.” PloS one vol. 20,5 e0322211. 8 May. 2025, doi:10.1371/journal.pone.0322211
  • Lemos, Isabel et al. “Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling in the ES-2 Ovarian Carcinoma Cell Line, Influencing Cell Proliferation, Quiescence, and Chemoresistance in a Cell-of-Origin-Specific Manner.” Metabolites vol. 15,4 244. 2 Apr. 2025, doi:10.3390/metabo15040244
  • Lemos, Isabel et al. “Cell-Free DNA (cfDNA) Regulates Metabolic Remodeling, Sustaining Proliferation, Quiescence, and Migration in MDA-MB-231, a Triple-Negative Breast Carcinoma (TNBC) Cell Line.” Metabolites vol. 15,4 227. 27 Mar. 2025, doi:10.3390/metabo15040227
  • Mendes, Cindy et al. “Metabolic profiling and combined therapeutic strategies unveil the cytotoxic potential of selenium-chrysin (SeChry) in NSCLC cells.” Bioscience reports vol. 44,7 (2024): BSR20240752. doi:10.1042/BSR20240752
  • Freitas-Dias, Catarina et al. “Interaction between NSCLC Cells, CD8+ T-Cells and Immune Checkpoint Inhibitors Potentiates Coagulation and Promotes Metabolic Remodeling-New Cues on CAT-VTE.” Cells vol. 13,4 305. 7 Feb. 2024, doi:10.3390/cells13040305
  • Hipólito, Ana et al. “H2S-Synthesizing Enzymes Are Putative Determinants in Lung Cancer Management toward Personalized Medicine.” Antioxidants (Basel, Switzerland) vol. 13,1 51. 28 Dec. 2023, doi:10.3390/antiox13010051
  • Kulig, Kamila et al. “Stress Conditions Affect the Immunomodulatory Potential of Candida albicans Extracellular Vesicles and Their Impact on Cytokine Release by THP-1 Human Macrophages.” International journal of molecular sciences vol. 24,24 17179. 6 Dec. 2023, doi:10.3390/ijms242417179
  • Martins, Filipa et al. “Metabolic Profiles Point Out Metabolic Pathways Pivotal in Two Glioblastoma (GBM) Cell Lines, U251 and U-87MG.” Biomedicines vol. 11,7 2041. 20 Jul. 2023, doi:10.3390/biomedicines11072041
  • Borkowska, Paulina et al. “Effects of the Co-Overexpression of the BCL and BDNF Genes on the Gamma-Aminobutyric Acid-Ergic Differentiation of Wharton's-Jelly-Derived Mesenchymal Stem Cells.” Biomedicines vol. 11,6 1751. 18 Jun. 2023, doi:10.3390/biomedicines11061751
  • Borkowska, Paulina et al. “Survival and Neurogenesis-Promoting Effects of the Co-Overexpression of BCLXL and BDNF Genes on Wharton's Jelly-Derived Mesenchymal Stem Cells.” Life (Basel, Switzerland) vol. 12,9 1406. 9 Sep. 2022, doi:10.3390/life12091406
  • Nunes, Sofia C et al. “Cysteine Boosts Fitness Under Hypoxia-Mimicked Conditions in Ovarian Cancer by Metabolic Reprogramming.” Frontiers in cell and developmental biology vol. 9 722412. 11 Aug. 2021, doi:10.3389/fcell.2021.722412
  • Borkowska, Paulina et al. “Synergistic Effect of the Long-Term Overexpression of Bcl-2 and BDNF Lentiviral in Cell Protecting against Death and Generating TH Positive and CHAT Positive Cells from MSC.” International journal of molecular sciences vol. 22,13 7086. 30 Jun. 2021, doi:10.3390/ijms22137086
  • Lopes-Coelho, Filipa et al. “The Activation of Endothelial Cells Relies on a Ferroptosis-Like Mechanism: Novel Perspectives in Management of Angiogenesis and Cancer Therapy.” Frontiers in oncology vol. 11 656229. 10 May. 2021, doi:10.3389/fonc.2021.656229
  • Dzung, Andreas et al. “Prolonged Unfrozen Storage and Repeated Freeze-Thawing of SARS-CoV-2 Patient Samples Have Minor Effects on SARS-CoV-2 Detectability by RT-PCR.” The Journal of molecular diagnostics : JMD vol. 23,6 (2021): 691-697. doi:10.1016/j.jmoldx.2021.03.003
  • Polisetti, Naresh et al. “Isolation and ex vivo Expansion of Human Limbal Epithelial Progenitor Cells.” Bio-protocol vol. 10,18 e3754. 20 Sep. 2020, doi:10.21769/BioProtoc.3754
  • Mendes, Cindy et al. “Unraveling FATP1, regulated by ER-β, as a targeted breast cancer innovative therapy.” Scientific reports vol. 9,1 14107. 1 Oct. 2019, doi:10.1038/s41598-019-50531-3
  • Steuer, Anna et al. “Cell stimulation versus cell death induced by sequential treatments with pulsed electric fields and cold atmospheric pressure plasma.” PloS one vol. 13,10 e0204916. 12 Oct. 2018, doi:10.1371/journal.pone.0204916
  • Nunes, Sofia C et al. “Cysteine allows ovarian cancer cells to adapt to hypoxia and to escape from carboplatin cytotoxicity.” Scientific reports vol. 8,1 9513. 22 Jun. 2018, doi:10.1038/s41598-018-27753-y
  • Nunes, Sofia C et al. “Cysteine boosters the evolutionary adaptation to CoCl2 mimicked hypoxia conditions, favouring carboplatin resistance in ovarian cancer.” BMC evolutionary biology vol. 18,1 97. 19 Jun. 2018, doi:10.1186/s12862-018-1214-1
  • Clausse, V et al. “Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.” Cell death & disease vol. 7,4 e2195. 14 Apr. 2016, doi:10.1038/cddis.2016.96

Related Products

    Ilex Life Sciences LLC is an authorized distributor of PAN-Biotech products.